Table 1.

Clinical and biological characteristics of AML patients

Patients	Age	Sex	Previous malignant disease	FAB	Membrane molecules					Karyotype	FLT3 LM	FLT3 Asp835	Survival (Weeks)
					CD 13	CD 14	CD 15	CD 33	CD 34
# 1	72	M	Residive	AML M1	+	-	+	+	-	Normal	wt	wt	6
# 2	34	F	-	AML M5a	-	-	+	+	-	46 XX, t(9;11), (q22;q23)	wt	0.31	>24 (Tx)
# 3	55	M	-	Atypical	+	-	+	+	-	Multiple	wt	wt	>23

The patients were randomly selected; their clinical and biological data are included as background information.